Business Wire

Steady concentration PD with the Carry Life UF system increased ultrafiltration nearly threefold and sodium removal nearly tenfold vs 2.5% dextrose CAPD, while improving glucose efficiency and supporting enhanced fluid management in PD patients

4.6.2026 16:45:00 CEST | Business Wire | Press Release

Share

Triomed AB today announced positive results from a prospective, multicenter, randomized, crossover study evaluating steady concentration peritoneal dialysis using the Carry Life UF system in adult patients undergoing CAPD. The study demonstrated significant improvements in ultrafiltration, peritoneal sodium removal and glucose ultrafiltration efficiency (ultrafiltration volume in relation to glucose absorption) compared with standard 2.5% dextrose CAPD in the home setting over four weeks. The study results were presented as a Focussed Oral presentation based on a late-breaking clinical trial abstract at the European Renal Association (ERA) Congress in Glasgow, United Kingdom, and simultaneously published in the Journal of the American Society of Nephrology (JASN).

In this study, participants received their standard CAPD treatment during the control arm, whereas in the Carry Life UF arm, one daily 2.5% dextrose exchange was replaced by a Carry Life UF treatment three days per week, and by a 1.5% dextrose CAPD exchange on the remaining four days. A total of 19 participants completed the study (mean age 56 years, six women, seven participants had diabetes).

The ultrafiltration volume primary endpoint was met, with Carry Life UF demonstrating superiority over control by exceeding the prespecified superiority margin of 250 mL. The mean increase in ultrafiltration volume was 381 mL (95% CI, 285 to 477), with a mean ultrafiltration volume of 513 mL for the Carry Life UF total group compared with 132 mL for the control. Carry Life UF also resulted in greater peritoneal sodium removal compared with control, with a mean increase of 43 mmol per exchange (95% CI, 32 to 54), reflecting a mean of 48 mmol per exchange with Carry Life UF versus 5.5 mmol with control. Glucose ultrafiltration efficiency was more than twice that of control, indicating that increased peritoneal fluid removal can be achieved with lower glucose absorption. The adverse event profile observed in the study was reassuring, with no unexpected safety signals and similar frequency in two study arms.

“Steady concentration peritoneal dialysis delivered with the Carry Life UF system has the potential to enable a step change in the prescription of peritoneal dialysis, reducing the need for hypertonic dextrose solutions while delivering effective ultrafiltration and peritoneal sodium removal,” said Associated Professor Olof Heimbürger, Senior Nephrologist at Karolinska Institutet, Stockholm, Sweden. “Fluid overload remains one of the most important challenges in peritoneal dialysis, affecting a large proportion of patients and contributing to increased morbidity and mortality. The Carry Life UF system may offer a new approach to reduce uncontrolled fluid overload and the risk of transition to hemodialysis.”

“Triomed is using these findings to support ongoing regulatory applications in Europe for the Carry Life UF system, while planning a registry study as part of post-market clinical follow-up to further evaluate steady concentration peritoneal dialysis in real-world clinical practice, and further a pediatric investigation as required by the European Medicines Agency,” said Mats Wahlström, Chairman of the Board of Triomed. “We are extremely grateful to the Triomed team for their tireless efforts in advancing this technology, and to the investigators for their rigorous work in conducting the study, as well as to all our dedicated investors for their continued long-term support in enabling the development of this breakthrough innovation.”

To learn more: triomed.se or triomed.se/news-and-events/ or follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604031893/en/

Contacts

Refer to: Marcello Grondelli, Eng., CEO of Triomed AB,
marcello.grondelli@triomed.se

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB Selected by Vår Energi for Integrated Drilling Services Offshore Norway12.11.2026 13:50:00 CET | Press Release

Global energy technology company SLB (NYSE: SLB) today announced it has been selected by Vår Energi as its main integrated drilling services supplier for the Transocean Barents and Deepsea Bergen rigs on the Norwegian Continental Shelf. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111105994/en/ SLB (NYSE: SLB) has been selected by Vår Energi as its main integrated drilling services supplier for the Transocean Barents and Deepsea Bergen rigs on the Norwegian Continental Shelf. The selection covers an initial four-year period, with four additional one-year extension options that could extend the scope through 2034. Two harsh-environment semisubmersibles will continuously drill exploration and development wells during this period. The integrated delivery model brings together technical expertise, digital workflows and operational execution across the well delivery process. Working closely with Vår Energi and other selected

Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States12.11.2026 13:35:00 CET | Press Release

Takeda (TSE:4502/NYSE:TAK) announced that ORZEYFUL™ (oveporexton) CIV is now available in the U.S. by prescription for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults, bringing the first and only orexin agonist to this community. Learn more at ORZEYFUL.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111123458/en/ Orzeyful Logo “Living with narcolepsy type 1 is an ongoing struggle to keep it together – from scheduling naps and anticipating sleep attacks to figuring out how to be present as a mom and a professional,” said Emily P., clinical trial participant with NT1. “With ORZEYFUL, I feel more confident planning my day because my narcolepsy has become more manageable.” Driven by orexin deficiency, the persistent 24-hour nature of NT1 affects far more than daytime sleepiness; it shapes how people plan their days and navigate many parts of their lives. What others might do without thinking

MultiBank Group and Universal Sign Agreement to Develop USDU Settlement Capabilities for Institutional Clients12.11.2026 13:02:00 CET | Press Release

MultiBank Group, one of the world’s largest financial derivatives institutions, has signed a memorandum of understanding (MoU) with Universal Digital Intl Limited (“Universal”) to develop settlement capabilities using USDU, Universal’s US dollar-backed stablecoin, for eligible institutional digital asset transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112192767/en/ MultiBank Group, one of the world’s largest financial derivatives institutions, has signed a memorandum of understanding (MoU) with Universal Digital Intl Limited (“Universal”) to develop settlement capabilities using USDU, Universal’s US dollar-backed stablecoin, for eligible institutional digital asset transactions. The initiative will begin with a pilot for eligible Professional Clients on mb.io, the Group’s cryptocurrency and digital asset trading platform. It combines MultiBank Group’s trading infrastructure, institutional relationships and li

IFF Launches CONCEPT MUSE, an AI-Powered Platform Designed to Accelerate Food and Beverage Product Development12.11.2026 13:00:00 CET | Press Release

IFF (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences—today announced the launch of CONCEPT MUSE, a proprietary AI-powered tool for food and beverage concept generation. Drawing from IFF’s consumer insights, flavor expertise and market intelligence, CONCEPT MUSE helps identify market opportunities and uses simple prompts to generate differentiated concepts—complete with narratives, visual mockups and suggested technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111590865/en/ IFF's CONCEPT MUSE helps identify market opportunities and uses simple prompts to generate differentiated concepts. “Food and beverage innovation has always been a balance of art and science. Now digital transformation is adding a powerful new dimension to that equation,” said Benjamin Mattei, vice president of intelligence and digital transformation for IFF Taste. “CONCEPT MUSE is where AI meets human imagination

Carbon Measures Opens Singapore Office and Launches First In-Country Pilot to Advance Industrial Decarbonization in Hard-to-Abate Sectors12.11.2026 12:00:00 CET | Press Release

Today, at COP31, Carbon Measures announced the establishment of its Singapore office, with support from the Singapore Economic Development Board (EDB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112827071/en/ Carbon Measures opens Singapore office and launches first in-country pilot to advance industrial decarbonization in hard-to-abate sectors. The Singapore office will serve as Carbon Measures’ Asia-Pacific hub, expanding its technical expertise and knowledge capabilities while strengthening engagement with key stakeholders across the region. The office will focus on advancing industrial decarbonization policies for hard-to-abate sectors, convening companies, nonprofit organizations, academic institutions and other partners to guide the Pilot’s development and implementation. “We welcome Carbon Measures’ establishment of its first office in the region. By piloting new approaches for product-level carbon accounting,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye